Compare KRSP & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KRSP | FDMT |
|---|---|---|
| Founded | 2025 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 474.3M | 515.6M |
| IPO Year | N/A | 2019 |
| Metric | KRSP | FDMT |
|---|---|---|
| Price | $10.30 | $10.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $31.71 |
| AVG Volume (30 Days) | 12.1K | ★ 845.1K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $85,209,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $70.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 230194.60 |
| 52 Week Low | $10.21 | $3.03 |
| 52 Week High | $10.70 | $12.34 |
| Indicator | KRSP | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 48.13 | 55.05 |
| Support Level | $10.25 | $9.85 |
| Resistance Level | $10.39 | $10.69 |
| Average True Range (ATR) | 0.03 | 0.53 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 25.00 | 60.77 |
Rice Acquisition Corp 3 is a blank check company.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).